Sign in

You're signed outSign in or to get full access.

Thomas R. Tyrrell

Director at CHEMUNG FINANCIAL
Board

About Thomas R. Tyrrell

Independent director of Chemung Financial Corporation (CHMG) since 2014; age 74 as of January 1, 2025. Vice President at NFP, an Aon Company, since 2014; previously Albany Area Chairman at Arthur J. Gallagher & Co., focused on surety and P&C insurance for construction. Core credentials include business management, sales, business ownership experience, and service on non-profit boards. He is classified as independent under NASDAQ listing standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
NFP, an Aon CompanyVice PresidentSince 2014 Insurance agency leadership; risk products for construction
Arthur J. Gallagher & Co.Albany Area Chairman (former)Formerly (dates not disclosed) Regional leadership in surety and P&C insurance for construction

External Roles

OrganizationRolePublic Company Directorship?Notes
NFP, an Aon CompanyVice PresidentNot disclosedExternal executive role; no other public boards disclosed in CHMG proxy

Board Governance

AttributeDetails
Committee membershipsAudit Committee member; Compensation & Personnel Committee member; Chair, Nominating & Governance Committee
Independence statusDetermined independent; meets stricter SEC/NASDAQ independence requirements for Audit and Compensation Committees
Years of service on CHMG boardDirector since 2014
Executive sessionsIndependent directors held two executive sessions in 2024; three in 2023
AttendanceEach director attended at least 75% of assigned Board and committee meetings in 2024 and 2023 (individual percentages not disclosed)
Board leadershipCEO and Chair roles separated; Chair presides over executive sessions (Chair: David J. Dalrymple)
Executive Committee (historical)Member of Executive Committee; committee met two times in 2023

Fixed Compensation

YearFees Earned or Paid in Cash ($)Stock Awards ($)All Other Compensation ($)Total ($)
202332,500 29,002 588 (dividends on restricted stock) 62,090
202431,250 29,010 (grant date fair value) 2,257 (advisory fees/dividends/mileage per footnotes) 62,517

Director fee schedule (latest disclosed):

  • Annual retainer: $11,500
  • Meeting fees: $500 per Board or committee meeting (including chairs)
  • Chair supplemental retainers/fees (examples): Chair of Board supplemental $7,750; Audit Chair supplemental $2,875; Nominating & Governance Chair fees $250; Compensation Chair fees $750; Committee chair fees vary by committee

Directors’ Deferred Fee Plan available (elective deferral into stock-denominated units; not disclosed that Tyrrell participates) .

Performance Compensation

Grant YearGrant DateShares (Unvested at Year-End)Grant Date Fair Value ($)Vesting Schedule
20231/19/2023 632 (awarded in 2023; unvested at 12/31/2023) 29,002 Director grants vest fully on the first anniversary of grant date
20241/17/2024 603 (unvested at 12/31/2024) 29,010 Director grants vest fully on the first anniversary of grant date

Plan features and metrics:

  • Equity awards under 2025 Equity Incentive Plan include restricted stock and RSUs; minimum 1-year vesting for directors (earlier of one-year or next annual meeting ≥50 weeks after prior meeting) .
  • Clawback: awards subject to clawback upon misconduct-related restatement; also subject to any CHMG clawback policy .
  • Performance awards (if used) may reference metrics such as ROE, diluted EPS, net income, efficiency ratio, growth in loans/deposits, NPLs, etc. (no director-specific performance awards disclosed) .

Other Directorships & Interlocks

CompanyRoleInterlock/Related PartyStatus
None disclosedNo other public company boards disclosed for Tyrrell in CHMG proxies

Related party transactions (board-wide):

  • No transactions disclosed involving Tyrrell. A separate lease with an entity affiliated with Director David M. Buicko is disclosed; audit/independence reviews affirmed terms as ordinary course and arms-length. Aggregate loans to directors/executives and related parties were $25.4M as of 12/31/2024; all ordinary course and performing.

Expertise & Qualifications

  • Insurance and risk management expertise via senior roles at NFP and Arthur J. Gallagher, supporting oversight of governance and risk areas.
  • Experience in business management, sales, and business ownership; service on non-profit boards; suitable for Nominating & Governance chairmanship.

Equity Ownership

As of Record DateBeneficially Owned Shares (#)Unvested Restricted Shares (#)% of Outstanding Shares
April 8, 20247,787 (includes 603 unvested RS) 603 <1% (based on 4,751,977 shares outstanding)
April 7, 20258,533 (includes 603 unvested RS) 603 <1% (based on 4,789,963 shares outstanding)

Alignment policies:

  • Anti-hedging and anti-pledging policy prohibits short sales, derivatives, and pledging/margin accounts for directors and executives.

Governance Assessment

  • Independence and committee leadership: Tyrrell is independent and chairs Nominating & Governance, with memberships on Audit and Compensation—positions requiring heightened independence—supporting board effectiveness.
  • Engagement: Board held 12 meetings in 2024; all directors met at least 75% attendance; independent directors met in executive session twice (2024) and three times (2023), indicating active oversight.
  • Ownership alignment: Holds 8,533 shares (including 603 unvested restricted shares) as of April 7, 2025; director equity grants vest annually, reinforcing alignment; anti-hedging/pledging policy strengthens alignment.
  • Compensation mix: Receives balanced cash fees plus annual time-based restricted stock (2023 total $62,090; 2024 total $62,517), typical for community bank boards; no performance-linked director grants disclosed.
  • Conflicts and related-party exposure: No related-party transactions disclosed for Tyrrell; board has processes for review and approval of any director transactions; notable related-party lease involves a different director.
  • Executive Committee concentration risk (mitigated): Tyrrell served on the Executive Committee, which has full Board authority but met only twice in 2023, limiting concentration and indicating sparing use.
  • Shareholder support: Say-on-pay received ~96.6% approval in 2024 for 2023 NEO compensation, signaling broad investor confidence in CHMG’s governance and pay practices (contextual to overall governance environment).